Pages that link to "Q36710034"

The following pages link to Disruption of the Murine Glp2r Impairs Paneth Cell Function and Increases Susceptibility to Small Bowel Enteritis (Q36710034):

Displaying 28 items.

• Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 (Q26752511) (← links)
• The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease (Q26778350) (← links)
• Glucagon-like peptide-2 regulates release of chylomicrons from the intestine. (Q35046115) (← links)
• Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice (Q35986076) (← links)
• Association of Bactericidal Dysfunction of Paneth Cells in Streptozocin-Induced Diabetic Mice with Insulin Deficiency (Q36116340) (← links)
• Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues (Q36171894) (← links)
• Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure (Q36309586) (← links)
• The gastrointestinal immune system: Implications for the surgical patient. (Q36738035) (← links)
• Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art. (Q37071033) (← links)
• Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport (Q37662980) (← links)
• Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis (Q38048602) (← links)
• On the horizon: trophic peptide growth factors as therapy for neonatal short bowel syndrome (Q38711705) (← links)
• Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway (Q38744556) (← links)
• Gastrointestinal immune and microbiome changes during parenteral nutrition. (Q39116552) (← links)
• GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation. (Q39473017) (← links)
• Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. (Q40074896) (← links)
• The endogenous preproglucagon system is not essential for gut growth homeostasis in mice (Q41038731) (← links)
• Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats (Q42943394) (← links)
• The gut as a sensory organ. (Q45894561) (← links)
• Role of Incretin Axis in Inflammatory Bowel Disease. (Q47103249) (← links)
• Increased gut permeability in cancer cachexia: mechanisms and clinical relevance. (Q53688957) (← links)
• Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice. (Q55280611) (← links)
• GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy (Q57107215) (← links)
• Glucagon-Like Peptide-2 and the Enteric Nervous System Are Components of Cell-Cell Communication Pathway Regulating Intestinal Na/Glucose Co-transport (Q58707940) (← links)
• The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice (Q88801926) (← links)
• Lipid malabsorption from altered hormonal signaling changes early gut microbial responses (Q89311714) (← links)
• Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function (Q89442824) (← links)
• Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice (Q90458241) (← links)